PHITAH
NanoGSkin-CB-2019
Phase 2 mab active
Quick answer
PHITAH for Basal Cell Carcinoma is a Phase 2 program (mab) at Lxo Ireland Designated Activity Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lxo Ireland Designated Activity Company
- Indication
- Basal Cell Carcinoma
- Phase
- Phase 2
- Modality
- mab
- Status
- active